Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Receivables - Net (2012 - 2014)

Updated

Skye Bioscience's Receivables - Net was $35,425 in Q1 2014.

Analysis

Skye Bioscience (SKYE) Receivables - Net (2012 - 2014) Analysis & Trends

At the end of FY2013, Receivables - Net at Skye Bioscience came in at $25,338, up 266.9% from FY2012.

  • In earlier years, Receivables - Net was $6,906 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Skye Bioscience 5.38 Mn -52.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2014 35,425.00
Oct 31, 2013 25,338.00
Jul 31, 2013 28,666.00
Apr 30, 2013 32,078.00
Oct 31, 2012 6,906.00
API Access

Skye Bioscience Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=SKYE&period=max&api_key=YOUR_API_KEY